SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-022872
Filing Date
2023-05-18
Accepted
2023-05-18 07:06:06
Documents
16
Period of Report
2023-05-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eypt-20230517.htm   iXBRL 8-K 110116
2 EX-2.1 eypt-ex2_1.htm EX-2.1 940092
3 EX-10.1 eypt-ex10_1.htm EX-10.1 259607
4 EX-99.1 eypt-ex99_1.htm EX-99.1 27568
5 GRAPHIC img96707757_0.jpg GRAPHIC 5406
  Complete submission text file 0000950170-23-022872.txt   1605749

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT eypt-20230517.xsd EX-101.SCH 2475
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT eypt-20230517_pre.xml EX-101.PRE 9457
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT eypt-20230517_lab.xml EX-101.LAB 12806
10 EXTRACTED XBRL INSTANCE DOCUMENT eypt-20230517_htm.xml XML 4523
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51122 | Film No.: 23933683
SIC: 3826 Laboratory Analytical Instruments